BKT

14.295

-1.82%↓

BKT

14.295

-1.82%↓

BKT

14.295

-1.82%↓

BKT

14.295

-1.82%↓

BKT

14.295

-1.82%↓

Equasens

Затворен

39.95 0.13

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

39.1

Максимум

40.1

Ключови измерители

By Trading Economics

Приходи

17M

Продажби

116M

P/E

Средно за сектора

16.841

Дивидентна доходност

3.07

Марж на печалбата

14.879

Служители

1,400

EBITDA

116M

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.07%

Следващи печалби

30.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

605M

Предишно отваряне

39.82

Предишно затваряне

39.95

Equasens Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

27.01.2026 г., 23:07 ч. UTC

Печалби

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27.01.2026 г., 21:27 ч. UTC

Печалби

Texas Instruments 4Q Sales Rise, Profit Falls

27.01.2026 г., 23:55 ч. UTC

Пазарно говорене

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

27.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27.01.2026 г., 23:39 ч. UTC

Пазарно говорене

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27.01.2026 г., 23:20 ч. UTC

Печалби

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27.01.2026 г., 23:20 ч. UTC

Печалби

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27.01.2026 г., 23:19 ч. UTC

Печалби

SK Innovation Posts Net Loss for Second Consecutive Year

27.01.2026 г., 23:19 ч. UTC

Печалби

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27.01.2026 г., 23:18 ч. UTC

Печалби

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27.01.2026 г., 23:18 ч. UTC

Печалби

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

27.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27.01.2026 г., 23:07 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27.01.2026 г., 22:17 ч. UTC

Пазарно говорене

U.S. Dollar Slips Following Trump Comments -- Market Talk

27.01.2026 г., 22:06 ч. UTC

Печалби

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27.01.2026 г., 21:51 ч. UTC

Печалби

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

27.01.2026 г., 21:43 ч. UTC

Печалби

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27.01.2026 г., 21:41 ч. UTC

Печалби

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27.01.2026 г., 21:38 ч. UTC

Печалби

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27.01.2026 г., 21:32 ч. UTC

Печалби

Ampol: Modest Profit From F&I International in 2025

27.01.2026 г., 21:32 ч. UTC

Печалби

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27.01.2026 г., 21:31 ч. UTC

Печалби

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27.01.2026 г., 21:31 ч. UTC

Печалби

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27.01.2026 г., 21:30 ч. UTC

Печалби

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27.01.2026 г., 21:29 ч. UTC

Печалби

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27.01.2026 г., 21:29 ч. UTC

Печалби

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27.01.2026 г., 21:28 ч. UTC

Печалби

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Сравнение с други в отрасъла

Ценова промяна

Equasens Прогноза

Консенсусна оценка

By TipRanks

0 ratings

0

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Equasens

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat